Despite advances in treatment regimens that comprise surgery, chemotherapy, and radiation, outcome of many brain tumors remains dismal, more so when they recur. The …
B Majc, M Novak, N Kopitar-Jerala, A Jewett, B Breznik - Cells, 2021 - mdpi.com
Glioblastoma is the most common brain malignant tumor in the adult population, and immunotherapy is playing an increasingly central role in the treatment of many cancers …
GBM is the most common primary brain tumor in adults, and the aggressive nature of this tumor contributes to its extremely poor prognosis. Over the years, the heterogeneous and …
A Jewett, J Kos, K Kaur, T Safaei, C Sutanto… - Molecular Therapy …, 2020 - cell.com
Natural killer (NK) cells are the key immune effectors with the ability to mediate selection and differentiation of a number of different cancer stem cells/undifferentiated tumors via lysis, and …
DJ Park, PS Sung, JH Kim, GW Lee… - … for immunotherapy of …, 2020 - ncbi.nlm.nih.gov
Background Natural killer (NK) cells can recognize and kill cancer cells directly, but their activity can be attenuated by various inhibitory molecules expressed on the surface. The …
Glioblastomas remain the most lethal primary brain tumors. Natural killer (NK) cell-based therapy is a promising immunotherapeutic strategy in the treatment of glioblastomas, since …
JI Luna, SK Grossenbacher, WJ Murphy… - Expert opinion on …, 2017 - Taylor & Francis
Introduction: Standard cytoreductive cancer therapy, such as chemotherapy and radiotherapy, are frequently resisted by a small portion of cancer cells with 'stem-cell'like …
The brain is considered an immune privileged site due to the high selectivity of the blood- brain barrier which restricts the passage of molecules and cells into the brain parenchyma …
We have recently shown that natural killer (NK) cells select and differentiate cancer stem cells (CSCs)/undifferentiated tumors via secreted and membrane bound IFN-gamma (IFN-γ) …